生物活性 | |||
---|---|---|---|
描述 | ML192 is a selective ligand antagonist of GPR55. ML192 inhibited L-α lysophosphatidylinositol or ML186-induced β-arrestin trafficking with IC50 values of 0.70 µM and 0.29 µM, respectively. ML192 significantly inhibited ERK1 in U2OS cells expressing GPRSS. ML192 significantly inhibited the phosphorylation of ERK1/2 in U2OS cells expressing GPRSS, with an IC50 value of 1.1 µM. ML192 reduced PKCβII translocation in wild-type GPR55 receptor cells at concentrations of 10, 30, and 100 µM[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.61mL 0.52mL 0.26mL |
13.07mL 2.61mL 1.31mL |
26.15mL 5.23mL 2.61mL |
参考文献 |
---|